These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30662590)

  • 61. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection.
    Li X; Gao X; Hu H; Xiao Y; Li D; Yu G; Yu D; Zhang T; Wang Y
    Front Microbiol; 2018; 9():2622. PubMed ID: 30450088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pancreatic Diseases and Microbiota: A Literature Review and Future Perspectives.
    Gesualdo M; Rizzi F; Bonetto S; Rizza S; Cravero F; Saracco GM; De Angelis CG
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33139601
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Intestinal microbiota - a vital "organ" with manifold functions].
    Konturek P; Konturek K; Zopf Y; Harsch IA
    MMW Fortschr Med; 2020 Mar; 162(Suppl 4):9-14. PubMed ID: 32189316
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
    Wilson BC; Vatanen T; Cutfield WS; O'Sullivan JM
    Front Cell Infect Microbiol; 2019; 9():2. PubMed ID: 30719428
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond
    Bakker GJ; Nieuwdorp M
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840809
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
    Zhou Y; Xu H; Huang H; Li Y; Chen H; He J; Du Y; Chen Y; Zhou Y; Nie Y
    Biomed Res Int; 2019; 2019():3469754. PubMed ID: 31467881
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic potential of fecal microbiota transplantation.
    Smits LP; Bouter KE; de Vos WM; Borody TJ; Nieuwdorp M
    Gastroenterology; 2013 Nov; 145(5):946-53. PubMed ID: 24018052
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Calcium supplementation modulates gut microbiota in a prebiotic manner in dietary obese mice.
    Chaplin A; Parra P; Laraichi S; Serra F; Palou A
    Mol Nutr Food Res; 2016 Feb; 60(2):468-80. PubMed ID: 26582185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders.
    Evrensel A; Ceylan ME
    Clin Psychopharmacol Neurosci; 2016 Aug; 14(3):231-7. PubMed ID: 27489376
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
    Kelly CR; Kahn S; Kashyap P; Laine L; Rubin D; Atreja A; Moore T; Wu G
    Gastroenterology; 2015 Jul; 149(1):223-37. PubMed ID: 25982290
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Fecal microbiota transplantation: review].
    Barbut F; Collignon A; Butel MJ; Bourlioux P
    Ann Pharm Fr; 2015 Jan; 73(1):13-21. PubMed ID: 25577013
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
    Carlucci C; Petrof EO; Allen-Vercoe E
    EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A novel polyphenolic prebiotic and probiotic formulation have synergistic effects on the gut microbiota influencing Drosophila melanogaster physiology.
    Westfall S; Lomis N; Prakash S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):441-455. PubMed ID: 29644870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
    Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
    Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.